tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

PHAT Stock Latest News

Phathom announces first patient dosed in Phase 2 pHalcon-EoE-201 trial
The FlyPhathom announces first patient dosed in Phase 2 pHalcon-EoE-201 trial
16d ago
PHAT
Phathom Pharmaceuticals Begins Phase 2 EoE Trial
PremiumCompany Announcements
Phathom Pharmaceuticals Begins Phase 2 EoE Trial
16d ago
8K
PHAT
Phathom Pharmaceuticals’ Q3 Earnings: Strong Growth Amid Challenges
PremiumCompany Announcements
Phathom Pharmaceuticals’ Q3 Earnings: Strong Growth Amid Challenges
19d ago
PHAT
Phathom Pharmaceuticals price target raised to $22 from $17 at Craig-Hallum
PremiumThe Fly
Phathom Pharmaceuticals price target raised to $22 from $17 at Craig-Hallum
20d ago
PHAT
Phathom Pharmaceuticals price target raised to $26 from $20 at H.C. Wainwright
PremiumThe Fly
Phathom Pharmaceuticals price target raised to $26 from $20 at H.C. Wainwright
20d ago
PHAT
Phathom Pharmaceuticals Reports Strong Q3 2025 Growth
PremiumCompany AnnouncementsPhathom Pharmaceuticals Reports Strong Q3 2025 Growth
20d ago
PHAT
Phathom Pharmaceuticals: Strong Q3 Performance and Promising Growth Drive Buy Rating
Premium
Ratings
Phathom Pharmaceuticals: Strong Q3 Performance and Promising Growth Drive Buy Rating
21d ago
PHAT
Phathom Pharmaceuticals reports Q3 adjusted EPS (15c), consensus (41c)
Premium
The Fly
Phathom Pharmaceuticals reports Q3 adjusted EPS (15c), consensus (41c)
21d ago
PHAT
Phathom Pharmaceuticals sees cash sufficient to fund operations in 2026
PremiumThe Fly
Phathom Pharmaceuticals sees cash sufficient to fund operations in 2026
21d ago
PHAT
Phathom Pharmaceuticals sees FY25 revenue $170M-$175M, consensus $170.4M
PremiumThe Fly
Phathom Pharmaceuticals sees FY25 revenue $170M-$175M, consensus $170.4M
21d ago
PHAT
Phathom Pharmaceuticals’ EoE Study: A Potential Game-Changer?
PremiumCompany Announcements
Phathom Pharmaceuticals’ EoE Study: A Potential Game-Changer?
23d ago
PHAT
Phathom Pharmaceuticals’ Vonoprazan Pregnancy Study: A Market Game Changer?
PremiumCompany Announcements
Phathom Pharmaceuticals’ Vonoprazan Pregnancy Study: A Market Game Changer?
24d ago
PHAT
Phathom Pharmaceuticals Publishes Phase 3 Trial Results
PremiumCompany AnnouncementsPhathom Pharmaceuticals Publishes Phase 3 Trial Results
24d ago
8K
PHAT
Phathom Pharmaceuticals Appoints New Chief Financial Officer
Premium
Company Announcements
Phathom Pharmaceuticals Appoints New Chief Financial Officer
1M ago
8K
PHAT
Phathom appoints Sanjeev Narula as chief financial, business officer
Premium
The Fly
Phathom appoints Sanjeev Narula as chief financial, business officer
1M ago
PHAT
Phathom clarifies no reduction in lead shareholder’s ownership amid 13D filing
PremiumThe Fly
Phathom clarifies no reduction in lead shareholder’s ownership amid 13D filing
3M ago
PHAT
Phathom Pharmaceuticals’ Earnings Call Highlights Growth and Challenges
PremiumCompany Announcements
Phathom Pharmaceuticals’ Earnings Call Highlights Growth and Challenges
3M ago
PHAT
Phathom Pharmaceuticals Reports Strong Q2 Growth
PremiumCompany Announcements
Phathom Pharmaceuticals Reports Strong Q2 Growth
3M ago
PHAT
Phathom Pharmaceuticals: Strong Buy Rating Driven by Robust Revenue Performance and Growth Potential
PremiumRatings
Phathom Pharmaceuticals: Strong Buy Rating Driven by Robust Revenue Performance and Growth Potential
3M ago
PHAT
Phathom Pharmaceuticals reports Q2 EPS (79c), consensus (89c)
PremiumThe FlyPhathom Pharmaceuticals reports Q2 EPS (79c), consensus (89c)
3M ago
PHAT
Phathom Pharmaceuticals sees 2025 revenue $165M-$175M, consensus $159.4M
Premium
The Fly
Phathom Pharmaceuticals sees 2025 revenue $165M-$175M, consensus $159.4M
3M ago
PHAT
Avidity, Phathom mentioned as potential takeout targets at Needham
Premium
The Fly
Avidity, Phathom mentioned as potential takeout targets at Needham
4M ago
BMY
NVO

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >